Towards a Typology of Business Models in the Biotechnology Industry

32 Pages Posted: 15 Nov 2017

Date Written: November 4, 2017

Abstract

The purpose of this paper is to identify a selection of key business models - “typology” - applied in the biotechnology industry. The focus is on the differences between traditional/closed or stand-alone business models opposed to open or networked business models.

A number of illustrative case studies and good practices are presented to show that new biotechnology firms are gradually adopting a “best of both worlds” strategy, with both closed business models and open, networked models as a way for gaining access to the market, in close collaboration with large global pharmaceutical companies. The case firms and good practices are taken from a recent country study for Belgium.

Keywords: Biotechnology, Business Models, Open Innovation

Suggested Citation

Segers, Jean-Pierre, Towards a Typology of Business Models in the Biotechnology Industry (November 4, 2017). Available at SSRN: https://ssrn.com/abstract=3065300 or http://dx.doi.org/10.2139/ssrn.3065300

Jean-Pierre Segers (Contact Author)

HEC-ULg University of Liège ( email )

Rue Louvrex
Liège, 4000
Belgium

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
251
Abstract Views
855
rank
136,649
PlumX Metrics